Overview
US post-acute care operator's Q1 revenue rose 18% yr/yr to $1.39 bln
Adjusted EPS for Q1 rose 22% yr/yr, beating analyst expectations
Company raised 2026 earnings and revenue guidance after strong Q1 and recent acquisitions
Outlook
Ensign raises 2026 diluted EPS guidance to $7.48-$7.62 from $7.41-$7.61
Company lifts 2026 revenue outlook to $5.81 bln-$5.86 bln from $5.77 bln-$5.84 bln
Ensign expects additional acquisitions in Q2 and Q3 2026 to support growth
Result Drivers
OCCUPANCY AND SKILLED MIX - Record occupancy rates and higher skilled patient volumes in Same and Transitioning Facilities drove revenue and earnings growth
ACQUISITIONS - Recent acquisitions, including 22 new operations, expanded the facility base and contributed to revenue growth
HIGHER MEDICARE AND MANAGED CARE VOLUMES - Increased Medicare and managed care census and revenue supported growth
Company press release: ID:nGNX4pQgKb
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Rental Revenue
$6.89 mln
Q1 Adjusted EPS
Beat
$1.85
$1.82 (5 Analysts)
Q1 EPS
$1.67
Q1 Net Income
$99.76 mln
Q1 Operating Income
$124.85 mln
Q1 Service Revenue
$1.38 bln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Ensign Group Inc is $222.00, about 19.1% above its April 29 closing price of $186.40
The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 24 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)